NCM · Medical - Devices

LNSR (LNSR) Stock

$5.25 -1.87% NCM: LNSR Healthcare

Valuation

MetricValue
Price$5.25
Market Cap$63.55M
P/E Ratio6.53
P/B Ratio3.17
P/S Ratio1.34
EPS (TTM)$-2.87
52-Week High$13.47
52-Week Low$5.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-514.92%
ROA44.39%
ROCE-34.18%
Gross Margin-43.10%
Operating Margin-43.10%
Net Margin50.94%
Debt/Equity0.10
Current Ratio1.15

Annual Financials (USD)

Metric20212022202320242025
Revenue$34.0M$35.0M$42.0M$53.0M$58.0M
Operating Profit$-20.0M$-20.0M$-12.0M$-11.0M$-25.0M
Net Profit$-20.0M$-20.0M$-14.0M$-31.0M$-34.0M
EPS$-2.10$-1.96$-1.31$-2.73$-2.87
Op Margin-57.0%-57.1%-29.0%-19.9%-42.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$66.0M$56.0M$70.0M$66.0M$71.0M
Total Liabilities$12.0M$14.0M$22.0M$48.0M$97.0M
Cash$32.0M$15.0M$21.0M$16.0M$13.0M
Borrowings$3.0M$3.0M$2.0M$3.0M$3.0M

Latest News

Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now? Zacks · Jul 2, 2026 How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target Simply Wall St. · Jun 4, 2026 Lensar (LNSR) Q1 2026 Earnings Transcript Motley Fool · Jun 1, 2026 Lensar (LNSR) Q4 2025 Earnings Transcript Motley Fool · Jun 1, 2026 LENSAR Q1 Earnings Call Highlights MarketBeat · May 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-9.0M$-15.0M$-10.0M$-2.0M$-15.0M
Investing Cash Flow$-1.0M$0$-4.0M$-2.0M$1.0M
Financing Cash Flow$0$-2.0M$6.0M$0$10.0M
Net Cash Flow$-9.0M$-17.0M$6.0M$-4.0M$-3.0M
Free Cash Flow$-9.0M$-15.0M$-10.0M$-2.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA1.99
FCF Yield-15.80%
Quick Ratio1.08
Interest Coverage0.00
Return 1Y-55.00%
Return 3Y59.05%
Return 5Y-22.59%

Ownership

Insiders Held21.53%
Institutions Held52.01%
Institutions Float Held66.28%
Institutional HolderSharesReport Date
Brandes Investment Partners L.P.1,025,1762026-03-31
Blackrock Inc.628,7482026-03-31
Vanguard Capital Management LLC390,0902026-03-31
Geode Capital Management, LLC229,7402026-03-31
Dimensional Fund Advisors LP224,9342026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANIK $19.61 -5.43% -19.58 $262.44M 0.00%
ARAY $0.28 +0.81% -15.50 $33.90M 0.00%
AVR $8.28 +0.00% -2.56 $304.61M 0.00%
CRBP $9.11 +0.33% -1.95 $168.79M 0.00%
CRDF $0.81 -2.98% -2.58 $53.22M 0.00%

About LNSR

LNSR is led by CEO Nicholas T. Curtis, employs 140 people, headquartered in US, publicly traded since 2020.

LNSR stock trades at $5.25 with a market capitalization of $63.55M. The stock is valued at a price-to-earnings (P/E) ratio of 6.53, price-to-book of 3.17, price-to-sales of 1.34. Over the past 52 weeks the stock has ranged between $5.06 and $13.47, and currently trades 61.0% below its 52-week high.

On profitability, LNSR generates a return on equity (ROE) of -514.92%, return on capital employed of -34.18%, an operating margin of -43.10%, a net profit margin of 50.94%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides